劳动
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
XY
Lv5
2
1460 积分
2023-10-14 加入
最近求助
最近应助
互助留言
Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis
3天前
已完结
The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats
6天前
已完结
Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin
8天前
已完结
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
10天前
已完结
A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice
14天前
已完结
AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
17天前
已完结
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
22天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
1个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
1个月前
已完结
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
1个月前
已完结
Standard Guide for Conducting Acute, Chronic, and Life-Cycle Aquatic Toxicity Tests with Polychaetous Annelids
1年前
已撤回
感谢
3天前
感谢
6天前
感谢
10天前
感谢
17天前
感谢
22天前
感谢
1个月前
感谢
1个月前
感谢
1个月前
点赞
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论